Should I buy Docusign (DOCU) stock or is it too late?

Docusign · Information Technology · price $64

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Citigroup — 63% of its targets hit on this sector (185 calls tested). It aims for $54 (-15 %), call made on June 6, 2026, maturing on June 6, 2027 (83 d ago).

The 3 reliable analysts $54-15 %

The 9 other firms $55-14 %

How to read it: the 3 reliable firms are not filtered by optimism — 0 aim above the price, 3 below, hence their $54 median. “The 9 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Docusign

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Wedbush	69 %	+63.1 %	13	$58 -9%
RBC Capital	50 %	+48.5 %	12	$55 -14%
JP Morgan	71 %	+37.5 %	7	$65 +2%
JMP Securities	50 %	+15.3 %	30	$124 +94%
Citigroup	48 %	+8.3 %	23	$54 -15%
Morgan Stanley	42 %	+1.3 %	12	$69 +8%
Wells Fargo	50 %	-8.0 %	8	$55 -14%
UBS	57 %	-12.3 %	7	$54 -15%

In short — Should you invest in Docusign? Is it too late, still worth it? Analysts are split (15% buy, median target $55, i.e. -14%), and the most reliable on DOCU targets even higher. But the stock is volatile, it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

The most reliable firm on DOCU, JP Morgan (71% hit rate, 7 scored calls), targets $65 (call made on March 18, 2026, maturing on March 18, 2027) (+2%) in its most recent call, and $80 (call made on September 5, 2025, maturing on September 5, 2026) (+25%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 13 ratings, 11 are neutral.
Limited upside: the median target is only -14% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.
No dividend: your return depends only on price appreciation.

The analyst consensus on DOCU

Median target $55 (-14%) · 13 ratings · Hold consensus

Strong Buy00%

Buy215%

Hold1185%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Docusign now?

We won't decide for you. The facts: 15% of analysts rate it a buy, median target $55 (-14%), and JP Morgan (most reliable on DOCU, 71%) targets $65. Weigh that against valuation and volatility. This is not personalized advice.

Is it too late to invest in Docusign?

The stated upside is small: the median target ($55) sits just -14% from the price ($64) (most reliable on DOCU: JP Morgan, 71%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Docusign still worth investing in?

It depends on the gap between the price ($64) and its estimated value: analysts target $55 on median (-14%), with 15% buys (most reliable on DOCU: JP Morgan, 71%). Cross-check with their real reliability on DOCU and the cautions above. Information, not advice.

What's the main risk in buying DOCU?

The consensus is not unanimous: of 13 ratings, 11 are neutral.

→ Go deeper: the full Docusign profile (consensus, analyst reliability, price target, performance).